Induction or Exacerbation of Psoriasis in Patients with Crohn's Disease under Treatment with Anti-TNF Antibodies

Extraintestinal manifestations and complications in IBD

(2013) Claudia Ott et al.   Nature Reviews Gastroenterology & Hepatology

Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci

(2012) David Ellinghaus et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases

(2012) Rafael Denadai et al.   Journal of Crohns & Colitis

Surgical management of Crohn’s disease

(2012) Virginia Oliva Shaffer et al.   LANGENBECKS ARCHIVES OF SURGERY

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

(2012) Lam C Tsoi et al.   NATURE GENETICS

Paradoxical inflammation induced by anti-TNF agents in patients with IBD

(2012) Isabelle Cleynen et al.   Nature Reviews Gastroenterology & Hepatology

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

(2011) G. Cullen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases

(2011) Warren Strober et al.   GASTROENTEROLOGY

Recent Insights Into the Genetics of Inflammatory Bowel Disease

(2011) Judy H. Cho et al.   GASTROENTEROLOGY

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients

(2011) Daniel C. Baumgart et al.   INFLAMMATORY BOWEL DISEASES

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases

(2011) Iván Guerra et al.   Journal of Crohns & Colitis

Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: The Mayo Clinic experience, 1998 to 2010

(2011) Eugenia Shmidt et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy

(2010) Jean–François Rahier et al.   Clinical Gastroenterology and Hepatology

Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease

(2010) Laurie S. Conklin et al.   Nature Reviews Gastroenterology & Hepatology

Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis

(2010) Angelique N. Collamer et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease

(2009) G. FIORINO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata

(2009) Uwe Wollina et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Cytokine imbalance with increased production of interferon-α in psoriasiform eruptions associated with antitumour necrosis factor-α treatments

(2009) J. Seneschal et al.   BRITISH JOURNAL OF DERMATOLOGY

Intestinal Effector T Cells in Health and Disease

(2009) Craig L. Maynard et al.   IMMUNITY

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES

Biologic Therapy(TNF-α Antagonists)-Induced Psoriasis

(2008) Raquel Cuchacovich et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

(2007) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY